NCT05897697View on ClinicalTrials.gov

Assessing Women's Preferences for Postpartum Thromboprophylaxis: the Prefer-Postpartum Study

CompletedOBSERVATIONAL
Enrollment

122

Participants

Timeline

Start Date

September 24, 2021

Primary Completion Date

October 7, 2022

Study Completion Date

October 7, 2022

Conditions
Venous ThromboembolismPregnancy Related
Interventions
OTHER

Interview

Structured interview

Trial Locations (2)

1205

Marc Blondon, Geneva

Unknown

Justine Hugon-Rodin, Paris

All Listed Sponsors
lead

Marc Blondon

OTHER

NCT05897697 - Assessing Women's Preferences for Postpartum Thromboprophylaxis: the Prefer-Postpartum Study | Biotech Hunter | Biotech Hunter